ONXEO (EPA:ALONX) | Finanzwire

Basculer en Français

9527	Companies
187412	Keywords
119446	Articles
100176	Press releases

Home
Companies
ONXEO

PRESS RELEASE

published on 10/30/2025 at 09:05, 1 month 16 days ago

Half-Year Financial Report 2025
BRIEF

published on 10/30/2025 at 09:03, 1 month 16 days ago

Valerio Therapeutics' financial and strategic review for the first half of 2025

Strategic Refocusing Valerio Therapeutics 2025 Financial Results V-Body Platforms Seeking Partnerships
PRESS RELEASE

published on 10/30/2025 at 09:00, 1 month 16 days ago

Press Release Publication Half-Year Financial Report 2025
Valerio Therapeutics S.A. announces first-half 2025 financial results, discontinuation of clinical activities, and strategic refocus on preclinical R&D. Strengthened financial structure through shareholder advances and capital increases

Financial Results Valerio Therapeutics First-half 2025 Preclinical R&D Shareholder Advances
BRIEF

published on 03/19/2025 at 15:32, 8 months 27 days ago

Valerio Therapeutics Announces Board Members and Their Roles

Board Members Valerio Therapeutics Corporate Roles Paris-based Company Executive Responsibilities
PRESS RELEASE

published on 03/19/2025 at 15:27, 8 months 27 days ago

Inside Information / Other news releases
Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025

Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF

published on 03/19/2025 at 12:35, 8 months 27 days ago

Valerio Therapeutics Board Meeting Decisions

Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments
PRESS RELEASE

published on 03/19/2025 at 12:30, 8 months 27 days ago

Inside Information / Other news releases
Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers

Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
BRIEF

published on 02/04/2025 at 10:40, 10 months 11 days ago

Valerio Therapeutics opts for strategic refocusing

Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
PRESS RELEASE

published on 02/04/2025 at 10:35, 10 months 11 days ago

Inside Information / Other news releases
Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development

Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
BRIEF

published on 10/01/2024 at 00:56, 1 year 2 months ago

Valerio Therapeutics Reports First Half 2024 Financial Results

Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies

Accesswire

Published on 12/15/2025 at 15:00, 1 hour 3 minutes ago

Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 1 hour 3 minutes ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 1 hour 33 minutes ago

Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 2 hours 3 minutes ago

Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 13:30, 2 hours 33 minutes ago

Greenlane Announces Results of Annual Meeting of Stockholders, Canopy Growth Co Founder Bruce Linton Joins Greenlane's Board of Directors

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 15:50, 13 minutes ago

Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen
Published on 12/15/2025 at 15:49, 14 minutes ago

Mutares submits an irrevocable offer to acquire Venator Ultramarine Blue Pigments business from Venator France SAS
Published on 12/15/2025 at 15:45, 18 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/15/2025 at 15:44, 18 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/15/2025 at 15:43, 19 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc

Les Echos

Published on 12/15/2025 at 11:50, 4 hours 13 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 22 hours ago

Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 09:15, 3 days 6 hours ago

CHANGE IN THE SHARE CAPITAL
Published on 12/11/2025 at 19:23, 3 days 20 hours ago

Eiffage is joining the CAC 40 index
Published on 12/11/2025 at 08:30, 4 days 7 hours ago

Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe

View all LES ECHOS COMFI WIRE